HER2-amplified Biliary Tract Cancers
1 clinical trials · Condition
◉ Watch HER2-amplified Biliary Tract Cancers
| Record | Firm | Date |
|---|---|---|
| A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers (NCT04466891) | Jazz Pharmaceuticals | 2020-10-01 |
Track HER2-amplified Biliary Tract Cancers automatically
Every clearance here is in the API, with alerts when new ones post.